Marshall Wace North America’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-6,521
Closed -$1.17M 1650
2021
Q1
$1.17M Buy
6,521
+3,460
+113% +$638K ﹤0.01% 993
2020
Q4
$564K Buy
3,061
+363
+13% +$59.7K ﹤0.01% 1065
2020
Q3
$406K Buy
+2,698
New +$423K ﹤0.01% 1011
2019
Q1
Sell
-1,248
Closed -$238K 1780
2018
Q4
$238K Buy
+1,248
New +$243K ﹤0.01% 925
2018
Q3
Sell
-15,418
Closed -$3.41M 1203
2018
Q2
$3.41M Buy
+15,418
New +$2.85M 0.02% 617
2017
Q4
Sell
-7,241
Closed -$1.1M 1519
2017
Q3
$1.1M Sell
7,241
-2,431
-25% -$368K 0.01% 924
2017
Q2
$1.36M Buy
+9,672
New +$1.37M 0.01% 839
2013
Q4
$9.21M Buy
+224,191
New +$9.13M 0.19% 125

Other funds holding MSGS

Marshall Wace North America's MSGS Position: Q2 2021 in Review

Marshall Wace North America sold out of Madison Square Garden (MSGS) in Q2 2021, closing a stake of 6,521 shares — an estimated $1.17M sold.

Marshall Wace North America first reported a position in MSGS in Q4 2013 and held it in 8 quarters. The position peaked at $9.21M in Q4 2013. 275 funds tracked by Wall St. Rank hold MSGS as of Q2 2021.

  • Marshall Wace North America reported no remaining Madison Square Garden position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 6,521 Madison Square Garden shares in Q2 2021, an estimated $1.17M.
  • Marshall Wace North America first reported a position in Madison Square Garden in Q4 2013 and held it in 8 quarters.
  • Marshall Wace North America's Madison Square Garden position peaked at $9.21M in Q4 2013.
  • 275 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.